Clinical Research Management announced it has been awarded a new, 5-year, $97MM research support contract titled Support for Military Medical Research for the Soldier (SMMRS) to be performed at the Walter Reed Army Institute of Research (WRAIR). The United States Army Medical Research Acquisition Activity (USAMRAA) awarded the contract to ClinicalRM. USAMRAA is both the contracting element of the US Army Medical Research and Materiel Command (USAMRMC) and the provider of support to the Command headquarters and its worldwide network of laboratories and medical logistics organizations.
Through the course of the contract, ClincalRM will provide support for WRAIR’s goal of improving both national and international efforts to develop drugs, vaccines and associated products to address diseases of strategic interest to the United States Military and to develop products to enhance warfighter resilience, and reduce and mitigate the impact of brain injury and combat stress.
“We are very proud of the support our company currently provides to WRAIR which makes this award especially important. It is a testament to the value we bring to critical research that supports the warfighter and our country,” said Victoria Tifft, founder and CEO of ClinicalRM.
For 18 years, ClinicalRM has proven itself as a trusted partner to the US Armed Forces providing basic and applied research, clinical trials, and regulatory approval for a wide variety of agents. The SMMRS contract start date is July 1, 2011.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.